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ABSTRACT We report a human band 3 alteration that is
associated with anemia as determined by a reticulocyte count
of 20%. Erythrocyte defects included increased IgG binding,
increased breakdown products of band 3, and altered anion-
and glucose-transport activity in middle-aged cells. These
changes were observed during normal erythrocyte aging in situ.
Binding of ankyrin to band 3 was normal. Serum/cell crossover
studies indicated that a neoantigen appears on the propositus'
erythrocytes to which IgG from both propositus and control
serum binds as measured with a protein A binding assay. IgG
eluted from the propositus' erythrocytes appeared to have a
specificity for senescent cell antigen as determined by a phago-
cytosis inhibition assay. Immunoelectron microscopy showed
that antibodies to band 3, which do not normally bind to intact
erythrocytes, bound to the propositus' erythrocytes. Antibody
980 binds to normal old cells but not young or middle-aged
cells. It also binds to a distinct region of band 3 in immunoblots
of membranes from the propositus' middle-aged cells. Cells
from both of the propositus' parents exhibited increased IgG
binding and altered anion and glucose transport. The results of
these studies suggest that (i) band 3 is aging prematurely in
erythrocytes from the propositus, (it) senescent cell antigen
appears on the propositus' middle-aged red cells, and (Ui) band
3 alterations observed in the propositus may have a genetic
component.
As part of our ongoing studies on mechanisms of cellular
aging, we searched for models of accelerated and decelerated
cellular aging. We anticipated that such models would allow
us to dissect molecular aging and provide insight into mech-
anisms. Initially, we investigated models for aging in vitro (1).
We subjected intact human erythrocytes to treatments that
have been reported to result in changes in band 3 (the major
anion-transport polypeptide) and/or to mimic aging in vitro.
The validity of these treatments as model systems for eryth-
rocyte aging was evaluated by using a "red cell aging panel"
that provides a biochemical profile of a senescent red cell (1,
2). Neither incubation with the free radical-generating xan-
thine oxidase/xanthine system nor treatment with malondi-
aldehyde, an end product of free radical-initiated lipid (per)-
oxidation, resulted in age-specific changes (1). Loading of the
cells with calcium and oxidation with iodate resulted in
increased breakdown of band 3 but did not lead to increased
binding of autologous IgG. Only erythrocytes that had been
stored for 3-4 weeks showed the same structural and func-
tional changes as observed during aging in vivo.
We then began a search for "experiments of nature" that
might provide insights into the process of normal cellular
aging (2). Initially, we studied glucose-6-phosphate dehydro-
genase (G6PD) deficiency and hemoglobin Koln as potential
models (2). Membranes from both the G6PD-deficient and the
hemoglobin Koin cells that we studied have been reported to
contain high molecular weight polymers (3). In addition,
hemoglobin Koln cells contain hemoglobin precipitates.
However, accelerated cellular aging was not present as
determined by a red cell aging panel including lack of
phagocytosis and IgG binding to young and middle-aged
erythrocytes, normal ankyrin binding, normal anion trans-
port, normal glyceraldehyde-3-phosphate dehydrogenase ac-
tivity, and no increase in band 3 breakdown products (2).
Therefore, we began a search for mutations and/or clinical
alterations of erythrocyte band 3. Our search for band 3
protein alterations resulted in the discovery of two different
ones (4, 5). One alteration, high molecular weight band 3,
results from an addition oftyrosine-containing peptides in the
transmembrane, anion-transport region of band 3 (4). It
appears to result from an autosomal recessive mutation. This
mutation is associated with acanthocyte ("thorny" cell)
formation. However, erythrocyte survival is normal in situ as
determined by the reticulocyte count, and the erythrocytes
do not exhibit accelerated aging as determined by the red cell
aging panel (4).
A second band 3 alteration also exhibits acanthocytosis (5).
This alteration is associated with ion- and glucose-transport
abnormalities and neurologic disease. The neurologic dis-
ease, choreoacanthocytosis, is an autosomal recessive.
In this paper, we describe a band 3 alteration that is
characterized by accelerated cellular aging, as determined by
a red cell aging panel, and cellular removal. The propositus'
reticulocyte count is =20%, indicating the destruction and
replacement in situ of 20% of circulating erythrocytes daily.
Both peripheral blood findings (e.g., the presence of nucle-
ated erythrocytes and precursors of monocytes and lympho-
cytes) and bone marrow biopsy are consistent with a hemo-
lytic anemia. We gave this band 3 alteration the descriptive
name "fast-aging" band 3 because the propositus' young and
middle-aged cells exhibit all the characteristics of old eryth-
rocytes (increased IgG binding, decreased anion and altered
glucose transport, and increased breakdown products of
band 3 as observed on immunoblots). Immunoelectron mi-
croscopy showed that antibodies to band 3, which do not bind
to normal intact erythrocytes, bind to intact middle-aged
erythrocytes from the propositus. Antibodies to aged band 3,
which do not bind to normal young or middle-aged red cells,
bind to a distinct region of band 3 in immunoblots of mem-
branes of the propositus' middle-aged red cells. We suspect
that fast-aging band 3 is more susceptible to proteolysis than
is normal band 3.
MATERIALS AND METHODS
General Cellular Methods. Erythrocytes from the proposi-
tus were studied in 10 different experiments over 27 months.
Family members were studied in three different experiments.
Red cells were separated into populations of different ages on
Percoll gradients (6). The amount of IgG on cells was
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quantitated with 125I-labeled protein A (7). Autoantibody was
eluted from erythrocyte membranes prepared by digitonin
lysis (8, 9) and the phagocytosis inhibition assay was per-
formed (8-11).
NaDodSO4/Polyacrylamide Gel Electrophoresis and Immu-
notaining Methods. Proteins were analyzed in NaDodSO4/
polyacrylamide 6-25% linear gradient gels with the discon-
tinuous buffer system of Laemmli (12). To remove carbohy-
drates, washed erythrocytes were treated with 9 units of
endoglycosidase F (New England Nuclear) in 10 volumes of
buffer for 2 hr at 370C (4). Enzymatic fragments of erythro-
cytes were generated by standard methods (4, 13, 14). Rabbit
antibody to band 3 and antibody 980, a rabbit antibody to
aged band 3 (precursor to senescent cell antigen), were
prepared as described (15-17). Monoclonal antibodies were
a gift from Michael Jennings (University of Texas at
Galveston). Immunoautoradiography was performed by the
immunoblotting technique of Towbin et al. (18) with the
modifications described previously (10, 13, 15, 16).
Transport Measurements. The "self-exchange flux" of
sulfate was determined at Donnan equilibrium, essentially by
the methods ofLepke and Passow (19) and Schnell et al. (20).
Measurements were made at six concentrations of sulfate
between 2 and 30 mM and at three time points within the first
8 min after the start of the assay. Ki, the sulfate concentra-
tion at which half the maximal velocity, Vn., is reached, was
determined by extrapolation from the linear part of the
velocity vs. concentration graph. Characteristics of the glu-
cose transport system (zero trans-exit and infinite trans-
entry) were determined by the methods of Naftalin et al. (21).
Vma,, and Km of zero trans-efflux (22) and Vmax of infinite
trans-entry were calculated from an integrated rate equation
(19).
Ankyrin Binding Studies. Ankyrin binding was studied by
the procedure of Hargreaves et al. (23) as described by
Goodman et al. (24). Data were corrected for nonspecific
binding (24) and plotted by using the Scatchard equation (25).
Protein was determined according to Lowry et al. (26).
Immunoelectron Microscopy. Immunoelectron microscopy
was performed as described (27, 28). Control and experimen-
tal cells were incubated with rabbit anti-human band 3 or
preimmune serum, washed, and incubated with F(ab')2 goat
anti-rabbit IgG conjugated to gold colloid.
RESULTS
IgG Binding to Erythrocytes. IgG binding to unseparated
and middle-aged cells from individuals with fast-aging band 3
was higher than that of normal controls (Table 1).
Antibodies Bound to Fast-Aging Erythrocytes Are Directed
Against Altered Band 3. The propositus had IgG on middle-
aged as well as old red cells, in contrast to normal individuals,
who have significant amounts of IgG only on old erythrocytes
(Table 1; refs, 1, 2, 4, 8-11). The presence in the propositus'
serum of an "abnormal" autoantibody against normal eryth-
rocytes was excluded on the basis of crossover experiments
in which control cells were incubated in either autologous or
propositus serum, and propositus cells were incubated in
autologous or control serum. As determined by binding of
1251I-labeled protein A, significantly more IgG bound to the
propositus' cells regardless of whether incubations were
performed in autologous or control serum (Table 2). This
indicates that IgG in normal serum recognizes the antigen
appearing on the propositus' erythrocytes and that the defect
resides in those erythrocytes. Incubation of the propositus'
erythrocytes in control serum resulted in increased IgG
binding as compared to incubations in autologous serum (P c
0.001), suggesting that the propositus' serum is depleted of a
normally occurring antibody, presumably physiologic IgG
autoantibody against senescent cell antigen.
Table 1. IgG binding to erythrocytes from individuals with






























































IgG binding was determined by using 125I-labeled protein A. Data
are presented as mean ± SD of 8-12 determinations.
*Second band of four bands of old cells on Percoll gradient.
tP c 0.001 compared to control cells.
tP 0.001 compared to control middle-aged cells.
§P 0.05 compared to control middle-aged cells.
These data suggested that the autoantibody might be
against senescent cell antigen, which is derived from band 3.
To test this hypothesis, a phagocytosis inhibition assay was
performed. Stored erythrocytes were phagocytosed when
they were incubated with IgG eluted from fast-aging cells (28
± 11% phagocytosis; P c 0.01 compared to controls) but not
when they were incubated with IgG eluted from an equal
volume of control cells (0%1o phagocytosis) or with IgG eluted
from fast-aging cells and absorbed with purified senescent
cell antigen (0%1o phagocytosis).
Table 2. Characterization of antibody binding to fast-aging
erythrocytes by crossover studies
Days in Cell Serum Bound IgG, no. of
serum source source molecules per cell
1 Control Propositus 22 ± 4t
Propositus Control 131 ± 5t
Control Control 16 ± 3
Propositus Propositus 41 ± 3
6 Control Control 51 ± 9
Propositus Control 386 ± 88t
Control Propositus 29 ± 1§
Propositus Propositus 103 ± 11*
10 Control Control 58 ± 5
Propositus Control 1092 ± 32t
Control Propositus 44 ± 4
Propositus Propositus 261 ± 13t
Results of Scatchard analysis of IgG binding to erythrocytes are
expressed as mean ± SD of four concentrations of protein A (n =
4-8). Cells were received on day 1.
*IgG bound was calculated by using a standard curve (7) for day 1.
tP - 0.05 for control cells in control serum compared to propositus
cells in control serum.
tP ' 0.001 for propositus cells in propositus serum compared to
propositus cells in control serum.
§P c 0.01 for control cells in control serum compared to propositus
cells in control serum.
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Antibody 980, which was raised against aged band 3, bound
to a distinct region of band 3 in immunoblots of membranes
prepared from the propositus' cells and from normal old cells
but not to band 3 in immunoblots of membranes from normal
young and middle-aged cells (Fig. 1). Antibody 980 did not
bind to band 3 of membranes of erythrocytes with a different
band 3 alteration, high molecular weight band 3 (Fig. 1B),
which does not result in shortened erythrocyte life-span (4).
These results suggest that senescent cell antigen and/or its
precursor molecule appears prematurely on the propositus'
erythrocytes. Thus, they appear to be aging prematurely.
Immunoelectron microscopy studies further suggested an
abnormal band 3 in the propositus' erythrocyte membranes.
The propositus' cells were labeled with rabbit antibody to
band 3, whereas normal control cells were not (Fig. 2).
Preimmune rabbit serum labeled neither propositus cells nor
control cells. We previously showed that neither human nor
rabbit antibodies to band 3 bind to normal erythrocytes (28).
Even enzymatic digestion of normal erythrocytes with tryp-
sin or chymotrypsin did not result in the level of binding
observed with the propositus' cells (28). The number of
antibody binding sites is sufficient to cause aggregation
following incubation with antibodies.
Increased Breakdown of Band 3 from Fast-Aging Cells.
Increased band 3 breakdown products were observed in
immunoblotting studies (Fig. 3). Changes in membrane pro-
teins other than band 3 were not detected. The electropho-
retic mobility ofband 3 from both control and propositus cells
was increased to the same extent following treatment with
endoglycosidase F, as would be expected following removal
of glycosyl groups.
Anion Transport. Unseparated and middle-aged red cells
from the propositus had abnormally decreased anion trans-
port (increased Km, decreased Vmx; Table 3). The mother
exhibited an increased Km. The parents' Vmx of sulfate
transport was normal in two experiments and decreased in
the other. The father, two siblings, and two daughters ex-
hibited normal Km of anion transport. Anion transport was
inhibited by 4,4'-diisothiocyanato-2,2'-stilbenedisulfonate
(DIDS). [3H]DIDS binding was the same for propositus (350
± 9 cpm) and control cells (330 ± 25 cpm). Increased Km and
decreased Vmax are observed in normal old human and rat
erythrocytes (10).
Glucose Transport. Erythrocytes from the propositus ex-
hibited slower glucose uptake (influx Vm.) and faster release
(zero trans-efflux Vmax) than normal cells (Table 4). The same
changes were observed in normal old erythrocytes. Cells
from both parents showed decreased glucose influx and
increased glucose efflux.
Ankyrin Binding. The number of high-affinity ankyrin
binding sites and the dissociation constant (Kd) for fast-aging
cells were the same as for control cells (data not shown).
Analysis of Band 3 Domains for Structural Alterations. The
anion transport studies suggested that the individual with
fast-aging band 3 had an alteration in the anion-transport
region of the protein. As a more definitive approach to
localizing and defining alterations in band 3, we performed
immunoblotting studies with monoclonal antibodies II E 1 (to
the Mr 17,000 transmembrane segment ofband 3) and IV F 12
[to the 150-residue region that is involved in ion transport (29)
on the M, 35,000 carboxyl-terminal segment of band 3].
Antibodies were used to probe immunoblots of both intact
and chymotrypsin-treated membranes (see legend to Fig. 4
for details). Results with monoclonal antibody II E 1 showed
that band 3 in inside-out vesicles prepared from fast-aging red
cell membranes was more susceptible to enzymatic digestion
because it was degraded to smaller fragments. Band 3 deg-
radation produced a Mr 17,000 fragment and a fragment
migratingjust below band 7 that was labeled with monoclonal
antibody II E 1 (Fig. 4). For molecular weight comparisons,
band 7 has Mr 29,000 and band 8 has Mr 24,000. Monoclonal
antibody IV F 12, directed against the Mr 35,000 carboxyl-
terminal segment, revealed only a faint band at Mr 60,000 in
autoradiographs of immunoblots of fast-aging "60R" mem-
branes (data not shown), corresponding to the band at Mr
60,000 in the amido black stain (Fig. 4, AB, lane f), suggesting
degradation to smaller fragments. A much larger band was
observed at Mr 60,000 in control "60R" membranes. In
addition, there was a band 3 breakdown product migrating in
the high 4.5 region in undigested membranes from fast-aging
but not control cells.
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FIG. 1. Binding of antibody 980 (anti-aged band 3) to immunoblots of erythrocyte membranes. Erythrocyte protein bands are numbered at
left. AB, amido black stain for proteins; AR, autoradiograph. (A) Lanes: a, normal young cells; b, normal upper middle-aged; c, normal middle
middle-aged; d, normal lower middle-aged; e, normal old (first band); f, normal old (second band, oldest erythrocytes); g, fast-aging band 3
(middle-aged erythrocytes from the propositus). (B) Lanes: a, normal membranes; b, from individual with fast-aging band 3; c, from individual
with high molecular weight band 3 mutation.
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FIG. 2. Electron micrographs of normal (A) and fast-aging (B)
erythrocytes incubated with antibodies to band 3 followed by gold
colloid conjugated to anti-rabbit IgG.
DISCUSSION
Middle-aged red cells with fast-aging band 3 exhibit the
following characteristics of senescent erythrocytes (1): in-
creased IgG binding, decreased sulfate transport (increased
Km, decreased Vm.), decreased glucose influx and increased
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FIG. 3. Immunoblotting
studies of membranes from
normal and fast-aging band 3
erythrocytes. AB, amido black
stain for proteins: AR, autora-
diograph. Lanes: a, mem-
branes prepared from erythro-
cytes of normal individuals
maintained as donors by our
laboratory and prepared imme-
diately; b, control membranes
drawn and prepared with those
of the experimental subjects;
AB AR c, propositus membranes.
Table 3. Sulfate transport by erythrocytes from individuals with
normal or fast-aging band 3
Cell Vmax, nmol per
Individual age Km, mM 108 cells per min
Experiment I
Control Middle 0.9 ± 0.1 132 ± 14
Control Old 1.6 ± 0.1* 77 ± 11*
Experiment 2
Control Middle 0.8 ± 0.1 112 ± 8
Propositus Middle 1.1 ± 0.1* 68 ± 8t
Mother Middle 1.0 ± 0.1t 83 ± 5*
Father Middle 0.8 ± 0.1 93 ± 6t
Experiment 3
Control Middle 1.0 ± 0.1 125 ± 7
Propositus Middle 1.4 ± 0.1* 98 ± 5*
Father Middle 0.9 ± 0.1 125 ± 9
Mother Middle 1.9 ± 0.1* 127 ± 10
Sibling 1 Middle 1.2 ± 0.1 111 ± 7
Sibling 2 Middle 0.8 ± 0.1 117 ± 10
Data are presented as mean ± SD. Anion transport by cells from
both daughters tested was normal (data not shown).
*P 0.01 compared to control middle-aged cells.
tP 0.001 compared to control middle-aged cells.
tP 0.05 compared to control middle-aged cells.
addition, antibodies to aged band 3 bind to band 3 in fast-
aging cells, but not in normal control cells or in cells with a
band 3 mutation that does not result in accelerated aging or
shortened erythrocyte life-span. This latter mutation results
in additional peptides in the anion-transport region of band 3
(9). Immunoelectron microscopy with antibodies to band 3
also suggests an altered band 3 in fast-aging cells. Further-
more, band 3 in inverted vesicles from fast-aging cells is more
sensitive to chymotrypsin digestion than that from control
cells.
Our interpretation of the data is that fast-aging band 3
results from a cellular alteration that renders the band 3
molecule more susceptible to proteolysis than normal band 3
under "stress" conditions. We think that the basic, under-
lying band 3 alteration (which we suspect is genetic) exhibited
by erythrocytes from the propositus and family members is
independent of the propositus' disease process but is a
contributing, perhaps predisposing, factor. Erythrocytes
from the propositus showed accelerated aging based on the
Table 4. Glucose transport by erythrocytes from individuals with
normal or fast-aging band 3
Cell Vmax, Amol per ml of cells per min
Individual age Influx Zero trans-efflux
Experiment I
Control Middle 10.4 ± 1.2 15.8 ± 0.6
Control Old 8.6 + 1.4* 29.1 ± 5.8t
Experiment 2
Control Middle 13.2 ± 1.0 17.1 ± 1.1
Propositus Middle 8.1 ± 1.1t 21.2 ± 0.7t
Experiment 3
Control Middle 12.1 ± 1.2 17.1 ± 0.7
Propositus Middle 9.2 ± 0.7* 20.1 ± 0.9t
Experiment 4
Control Middle 10.0 ± 1.3 17.2 ± 1.0
Propositus Middle 5.7 ± 0.4* 30.2 ± 1.6§
Father Middle 7.3 ± 0.1* 22.8 ± 1.0§
Mother Middle 6.5 ± 0.1t 20.4 ± 0.4*
Data are presented as mean ± SD.
*P 0.05 compared to control middle-aged cells.
tP s 0.01 compared to control middle-aged cells.
tP < 0.01 compared to control middle-aged cells.
§P < 0.001 compared to control middle-aged cells.
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FIG. 4. Binding of monoclonal antibody (II E 1) against the Mr 17,000 transmembrane, anion-transport segment of band 3 to immunoblots
of defined proteolytic fragments of band 3 from control membranes and membranes from an individual with fast-aging band 3. AB, amido black
stain for proteins; AR, autoradiograph; M, untreated membranes; C, control; F, fast-aging. Lanes: a, control untreated membranes (M); b,
membranes from individual with fast-aging band 3; c, control CH55 and CH38 fragments of band 3 produced by mild chymotrypsin treatment
of intact red cells; d, fast-aging CH55 and CH38 fragments; e, control Mr 60,000 carboxyl-terminal fragment (60R) remaining with the membrane
after removal of CH40 cytoplasmic segment by chymotrypsin treatment of inverted vesicles depleted of peripheral membrane proteins by alkali
treatment; f, fast-aging 60R; g, control Mr 17,000 transmembrane, anion-transport fragment of band 3 produced by treatment with chymotrypsin
at both sides of the membrane; h, fast-aging Mr 17,000 fragment. The bands at the bottom of the autoradiograph represent the Mr 17,000 segment
of band 3. During the blot transfer process, band 3, CH55, and 60R migrated through the nitrocellulose sheet because they were in lower-density
areas of the 6-25% gradient gel. The Mr 17,000 fragment was in the densest part of the gel and hence transferred slowly.
red cell aging panel. Although other family members (mother
and father) show subtle band 3 changes, their cells do not
show accelerated removal in situ. This suggests that they may
each have a subtle, perhaps different, alteration that com-
bines and contributes to the propositus' band 3 alteration
and/or susceptibility to damage. If this is genetic, it is
probably an autosomal recessive mutation or a change at
different alleles in each parent that combines in the proposi-
tus.
The immunologic band 3 defects revealed by binding of
antibodies to aged band 3, antibodies to band 3, and IgG in
situ and in vitro to the propositus' cells may be responsible
for the anemia.
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